Life sciences: Why execs are cautiously optimistic about 2026
The outlook for the global life sciences and medtech sectors is positive, but navigating the complex global landscape will require “innovative thinking, agile operating models, and robust external partnerships to help ensure sustained growth,” according to the 2026 Life Sciences Outlook released by Deloitte Insights.